Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Automatic continuous EEG signal analysis for diagnosis of delirium in patients with sepsis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: The complement system has been suggested to be involved in the pathophysiology of amyotrophic lateral sclerosis (ALS), a progressive motor neuron disease. In the present study, we compared levels of selected complement markers to clinical outcome in ALS patients.

Methods: This observational, explorative cohort study included 92 ALS patients, 61 neurological controls (NCs) admitted for suspected aneurysmal subarachnoid haemorrhage, and 96 neurologically healthy controls (NHCs). Peripheral blood and cerebrospinal fluid (CSF) were obtained for the measurement of ficolin-1, -2, and -3; collectin-11, MBL, MASP-3, MAP-1, C4, C3, PTX-3, and complement activation products C4c, C3bc, and sC5b-9. We recorded clinical outcomes of ALS patients for 24 to 48 months after inclusion in order to analyse the effects of the complement markers on survival time.

Results: Compared with both control groups, ALS patients exhibited increased collectin-11, C4 and sC5b-9 in plasma, as well as increased ficolin-3 in CSF. Ficolin-2 was significantly decreased in plasma of the ALS patients compared with NHCs, but not with NCs. The concentration of collectin-11, C3 and C3bc correlated negatively with the revised ALS functional rating scale (ALSFRS-R). No association was found between levels of complement markers and survival as estimated by hazard ratios.

Conclusion: ALS patients exhibit aberrant expression of selected mediators of the lectin complement pathway as well as increased activation of the terminal complement pathway, corroborating the notion that the complement system might be involved in the pathophysiology of ALS.

Original languageEnglish
JournalJournal of Inflammation Research
Volume14
Pages (from-to)1043-1053
Number of pages11
ISSN1178-7031
DOIs
Publication statusPublished - 2021

    Research areas

  • Amyotrophic lateral sclerosis, Cerebrospinal fluid, Complement, Innate immunity, Lectin pathway, Observational cohort study, Pathophysiology

ID: 64825784